Neoplastic meningitis in patients with adenocarcinoma of the gastrointestinal tract

Cancer

Volumn 103, Issue 11, 2005, Pages 2355-2362

  Giglio, Pierre ^a   Weinberg, Jeffrey S ^a   Forman, Arthur D ^a   Wolff, Robert ^a   Groves, Morris D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Adenocarcinoma; Gastrointestinal carcinoma; Leptomeningeal carcinomatosis; Neoplastic meningitis

Indexed keywords

AMSACRINE; CAPECITABINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; LOMUSTINE; MITOMYCIN C; PACLITAXEL; SPARFOSIC ACID; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COLON ADENOCARCINOMA; COLORECTAL ADENOMA; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; MALE; MENINGITIS; MORTALITY; NEOPLASTIC MENINGITIS; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RECTUM CARCINOMA; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ADULT; AGED; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MENINGEAL NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PALLIATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 18844449149     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21082     Document Type: Article

References (39)

1. Posner JB. Neurologic complications of cancer. Philadelphia: F.A. Davis Company, 1995.
2. Grove A. Meningeal carcinomatosis from a clinically undiagnosed early gastric cancer. Pathol Res Pract. 1991;187:341-345.
3. Deeb LS, Yamout BI, Shamseddine AI, et al. Meningeal carcinomatosis as the presenting manifestation of gastric adenocarcinoma. Am J Gastroenterol. 1997;92:329-331.
4. Kim M. Intracranial involvement by metastatic advanced gastric carcinoma. J Neurooncol. 1999;43:59-62.
5. Lee JL, Kang YK, Kim TW, et al. Leptomeningeal carcinomatosis in gastric cancer. J Neurooncol. 2003;66:167-174.
6. Fisher MA, Weiss RB. Carcinomatous meningitis in gastrointestinal malignancies. South Med J. 1979;72:930-932.
7. Beerman WF. Meningeal carcinomatosis. JAMA. 1912;58:1437-1439.
8. Cornwall LH. Metastatic meningo-encephalitic carcinomatosis without tumefaction. Arch Neurol Psychiatr. 1927;17:466-470.
9. Goldstein I, Wexter D. Metastasis in the sheath of the optic nerve from carcinoma of the stomach. Arch Ophthalmol. 1931;6:414-419.
10. Duncan CA. Meningeal carcinosis causing deafness. Med J Australia. 1941;2:541.
11. Dixon GJ, Kerr AS, Sharp ME. Meningitis carcinomatosa: a report on two cases. Brain. 1946;69:223-232.
12. Mallory TB, Castleman B, Towne VW. Case 37321 [colloid carcinoma of stomach with metastases to regional lymph nodes, meninges and cerebellum]. New Engl J Med. 1951;245:220-223.
13. McCormack LJ, Hazard JB, Gardner WJ, Klotz JG. Cerebrospinal fluid changes in secondary carcinoma of the meninges. Am J Clin Pathol. 1953;23:470-478.
14. Miessner GF. Carcinoma of the stomach with meningeal carcinosis: report of four cases. Cancer. 1953;6:313-318.
15. Grain GO, Karr JP. Diffuse leptomeningeal carcinomatosis. Clinical and pathologic characteristics. Neurology. 1955;5:706-722.
16. Heathfield KWG, Williams JRB. Carcinomatosis of the meninges; some clinical and pathological aspects. Br Med J. 1956;1:328-330.
17. Moberg A, von Reis G. Carcinosis meningum. Acta Med Scand. 1961;170:747-755.
18. Little JR, Dale AJD, Okazaki H. Meningeal carcinomatosis-clinical manifestations. Arch Neurol. 1974;30:138-143.
19. Agnelli G, Gresele P. Mucus-secreting "signet ring" cells in CSF revealing the site of primary cancer. Postgrad Med J. 1980;56:868-887.
20. Baltrucki LF, Spiers ASD, Davies JNP. Gastric cancer with chemotherapy-induced clinical remission and meningeal relapse. NY State J Med. 1982;82:745-748.
21. McCrary JA, Patrinely JR, Font RL. Progressive blindness caused by metastatic occult signet-ring cell gastric carcinoma. Arch Ophthalmol. 1986;104:410-413.
22. Lisenko Y, Kumar AJ, Yao J, et al. Leptomeningeal carcinomatosis originating from gastric cancer: report of eight cases and review of the literature. Am J Clin Oncol. 2003;26:165-170.
23. Teare JP, Whitehead M, Rake MO, et al. Rapid onset of blindness due to meningeal carcinomatosis from an oesophageal adenocarcinoma. Postgrad Med J. 1991;67:909-911.
24. Abdo AA, Coderre S, Bridges RJ. Leptomeningeal carcinomatosis secondary to gastroesophageal adenocarcinoma: a case report and review of the literature. Can J Gastroenterol. 2002;16:807-811.
25. Bresalier RS, Karlin DA. Meningeal metastasis from rectal carcinoma with elevated cerebrospinal fluid carcinoembryonic antigen. Dis Colon Rectum. 1979;22:216-217.
26. Fischer-Williams M, Bosanquet FD, Daniel PM. Carcinomatosis of the meninges; a report of three cases. Brain. 1955;78:42-58.
27. Kobayashi TK, Yamaki T, Yoshino E, et al. Immunocytochemical demonstration of carcinoembryonic antigen in cerebrospinal fluid with carcinomatous meningitis from rectal cancer. Acta Cytol. 1984;28:430-434.
28. Smith RS, Zatzkin JB, Hynes HE. Carcinomatous meningitis. J Kans Med Soc. 1984;85:9-10.
29. Chamberlain MC. A Phase II trial of intra-cerebrospinal fluid alpha interferon in the treatment of neoplastic meningitis. Cancer. 2002;94:2675-2680.
30. McFadzean R, Brosnahan D, Doyle D, et al. A diagnostic quartet in leptomeningeal infiltration of the optic nerve sheath. J Neuroophthalmol. 1994;14:175-182.
31. Willis RA. Pathology of tumours. London: Mosby, 1948.
32. Olson M, Chernik N, Posner J. Infiltration of the leptomeninges by systemic cancer. Arch Neurol. 1974;30:122-137.
33. Ferreira Filho AF, Cardoso F, Di Leo A, et al. Carcinomatous meningitis as a clinical manifestation of pancreatic carcinoma. Ann Oncol. 2001;12:1757-1759.
34. Chamberlain MC, Tsao-Wei D, Groshen S. Neoplastic meningitis-related encephalopathy: prognostic significance. Neurology. 2004;63:2159-2161.
35. Glantz MJ, Hall WA, Cole BF, et al. Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow status. Cancer. 1995;75:2919-2931.
36. Chamberlain MC, Kormanik PA. Prognostic significance of coexistent bulky metastatic central nervous system disease in patients with leptomeningeal metastases. Arch Neurol. 1997;54:1364-1368.
37. Friedberg MHF, Glantz MJF, Klempner MSF, et al. Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis. Cancer. 1998;82:923-930.
38. Garcia-Monco JF, Coleman JF, Benach J. Soluble urokinase receptor (uPAR, CD 87) is present in serum and cerebrospinal fluid in patients with neurologic diseases. J Neuroimmunol. 2002;129:216-223.
39. Stockhammer GF, Poewe WF, Burgstaller SF, et al. Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis. Neurology. 2000;54:1670-1676.